Catherine Moukheibir - Sep 15, 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Stock symbol
IRWD
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 05:05 PM
Previous filing
Jun 22, 2023
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +2.1K +1.68% $0.00 127K Sep 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.